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A quantitative proteomics screen to identify substrates of the Src family of tyrosine kinases (SFKs)
whose phosphorylation promotes CrkL-SH2 binding identiﬁed the known Crk-associated substrate
(Cas) of Src as well as the orphan receptor endothelial and smooth muscle cell-derived neuropilin-
like protein (ESDN). Mutagenesis analysis of ESDN’s seven intracellular tyrosines in YxxP motifs
found several contribute to the binding of ESDN to the SH2 domains of both CT10 regulator of kinase
(Crk)-Like (CrkL) and a representative SFK Fyn. Quantitative mass spectrometry showed that at least
three of these (Y565, Y621 and Y750), as well as non-YxxP Y715, are reversibly phosphorylated. SFK
activity was shown to be sufﬁcient, but not required for the interaction between ESDN and the CrkL-
SH2 domain. Finally, antibody-mediated ESDN clustering induces ESDN tyrosine phosphorylation
and CrkL-SH2 binding.
Structured summary of protein interactions::
CrkL-SH2 physically interacts with ESDN and CAS by pull down (View interaction)
CrkL-SH2 physically interacts with ESDN by pull down (View Interaction: 1, 2)
Fyn-SH2 physically interacts with ESDN by pull down (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Virtually all eukaryotic signaling pathways employ reversible
phosphorylation to effectuate cellular responses. Phosphorylation
not only alters local protein structure via simple electrostatic inter-
actions, but it also coordinates more sophisticated electrostatic
interactions that include the recruitment of proteins which havephosphorylation-dependent binding domains. These domains
recognize phosphotyrosine, phosphoserine or phosphothreonine
residues typically within a preferred linear sequence of amino
acids. Large-scale phosphoproteomics has made enormous strides
toward characterizing the preferred phosphorylation motifs for
speciﬁc kinases and the preferred binding motifs for individual
phosphorylation-dependent binding domains [1–4]. In addition,
the individual substrates of speciﬁc kinases and phosphorylation-
dependent binding domains are being delineated with impressive
speed and scale. As the methods and instrumentation for these
types of analyses have matured, our capacity to conduct more
functional proteomic analyses has also increased [1–4].
One type of functional proteomics analysis attempts to capture
a functional assemblage, drawing simultaneous connections be-
tween a kinase, a substrate and a downstream effector. Here we
describe the results of a screen to identify a novel substrate of
the Src family of tyrosine kinases (SFKs) that when phosphorylated
facilitates the binding of the CT10 regulator of kinase (Crk)-Like
(CrkL) adaptor protein via its SH2 domain. SFKs are perhaps the
best studied tyrosine kinases owing to the early discovery of Src’s
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in normal and aberrant biological processes [6–8], with its roles in
regulating cytoskeletal changes in diverse systems ranking as some
of its most important [9]. The adaptor protein Crk and its homolog
CrkL have similarly been well-studied given that Crk, like Src, was
initially identiﬁed as the cellular homolog of a transforming retro-
viral oncogene [10]. Furthermore, SFKs and Crk/CrkL have been
shown to coordinate their efforts in a variety of signaling pathways
with SFK substrates subsequently becoming scaffolds for Crk/CrkL.
Several examples of such substrates exist and include Crk-associ-
ated substrate (Cas), insulin receptor substrate-1 (IRS-1), Paxillin,
GRB2-associated-binding protein 1 (Gab1) and p62dok [10,11]. An-
other important example of this coordinated activity in neuronal
systems involves the scaffolding adaptor Disabled-1 (Dab1). The
phosphorylation of Dab1 by SFKs induces Crk/CrkL-binding and
this is critical for the proper positioning of neurons downstream
of Reelin signaling during the development of the vertebrate cen-
tral nervous system [12–15].
Given that SFKs and Crk/CrkL have emerged as critical collabo-
rators in several important systems, we conducted a functional and
quantitative proteomics screen toward the identiﬁcation of a novel
SFK substrate that also acted as a scaffold for the Crk/CrkL family of
adaptors. This yielded a relatively uncharacterized scaffolding
receptor, Endothelial and smooth muscle cell-derived neuropilin-
like protein (ESDN), also known as discoidin, CUB and LCCL domain
containing 2 (DCBLD2).
2. Materials and methods
2.1. Plasmids and site-directed mutagenesis
The expression construct for full-length human ESDN with Myc
and Flag (DDK) tags at the carboxyl-terminus in pCMV6-Entry was
obtained from Origene (product #RC224483; Rockville, MD). The
full-length human Fyn in pRK5 was acquired through Addgene
(plasmid 16032) and was originally constructed in the laboratory
of Filippo Giancotti [16]. The mutant ESDN constructs were
generated by Bio Basic Inc. (Markham, ON, USA) and are denoted
as follows: ESDN-Y1F (Tyr750Phe), ESDN-Y3F (Tyr750Phe,
Tyr732Phe and Tyr565Phe), and ESDN-Y7F (Tyr750Phe, Tyr732Phe,
Tyr677Phe, Tyr666Phe, Tyr655Phe, Tyr621Phe, and Tyr565Phe).
The bacterial expression plasmid for glutathione S-transferase
(GST)-CrkL-SH2 was a gift of A. Imamoto and was used as de-
scribed previously [13]. The bacterial expression plasmid for
GST-Fyn-SH2 was constructed ﬁrst by polymerase chain reaction
(PCR) ampliﬁcation of the SH2 domain using pRK5-Fyn as template
and the following primers: 50-CGCGCGAATTCGTTGACTCTATC-
CAGGCAGAAG-30 (forward, sense) and 50-GCGCGCGGCCGCGGTAA
GCCTTGGCATCCCTTTG-30 (reverse, anti-sense). The PCR reaction
was digested with EcoRI and NotI and the puriﬁed fragment was
cloned in-frame with GST in pGEX-4T-1 which had been cut with
EcoRI and NotI. The new clone was sequence-veriﬁed using the
University of Vermont/Vermont Cancer Center DNA analysis
facility.
2.2. Cell culture, transfections, stimulations and lysis
E1A-transformed Human embryonic kidney (HEK 293E) cells
were grown in DMEM (Mediatech, Manassas, VA, USA) supple-
mented with 5% Fetal Bovine Serum (FBS), 5% Cosmic Calf Serum
(sera were from Hyclone, Logan, UT, USA), 50 units/ml of penicillin
and 50 lg/ml of streptomycin. For stable-isotope labeling by amino
acids in cell culture (SILAC) experiments cells were grown as de-
scribed [17] and as detailed in the Supplementary methods. HEK
293E cells stably expressing ESDN-Myc-Flag were generated by
selecting G418-resistant transfected cells. The line used in thesestudies represents a mixed pool of more than a 100 stably-trans-
fected clones.
Transfections were performed by calcium phosphate precipita-
tion when cells were at 60–75% of conﬂuence. H2O2 stimulations
(8 mM) were for 15 min. PP2 (Sigma, Saint Louis, MO, USA) and
Src Inhibitor-1 (EMD-Calbiochem, Billerica, MA, USA) were dis-
solved in dimethyl sulfoxide and used at 2 or 10 lM as indicated
for 20 min prior to, and throughout the duration of, H2O2 stimula-
tions. Antibody stimulations were done by adding the antibody di-
rectly to the growth media for 20 min. Lysis is described in the
Supplementary methods.2.3. Pulldowns, immunoprecipitations, SDS–PAGE, immunoblots and
antibodies
For the initial large-scale pulldown, 20 mg of heavy protein
extract was mixed with 20 mg of light protein extract (1 mg/
ml). The mixture was divided in two, half of which was incubated
with 50 lg of GST on glutathione resin and half of which was incu-
bated with 50 lg of GST-CrkL-SH2 on glutathione resin. The incu-
bations were done on a rocker at 4 C overnight. The resins were
washed four times with lysis buffer and proteins were eluted with
protein sample buffer (150 mm Tris pH 6.8, 2% SDS, 5% b-mercap-
toethanol, 7.8% glycerol, 0.01% bromophenol blue) at 95 C for
5 min. Small-scale pulldowns used 2–5 lg of GST, GST-CrkL-SH2
or GST-Fyn-SH2 on glutathione resin and 200–800 lg of protein
extract. Immunoprecipitations were done using 200 lg of protein
extract and 20 ll of anti-Flag (M2) afﬁnity gel (Sigma). SDS–PAGE
was conducted on 10% (37.5:1 acrylamide:bis-acrylamide) gels.
Immunoblotting and mass spectrometry were conducted as de-
scribed previously [18] and as detailed in the Supplementary
methods. The anti-Flag (M2) antibody was from Sigma. The anti-
phosphotyrosine (4G10) and anti-GST (06-332) antibodies were
from Upstate Biotechnology/Milipore (Billerica, MA, USA). The
anti-Fyn (4023) and anti-alpha-tubulin (DM1A) antibodies were
from Cell Signaling Technology, Inc. (Danvers, MA, USA). The
anti-ESDN (E1781, Sigma) was raised against amino acids 399–
416 of human ESDN which is in the middle of the factor V/VIII
domain.
3. Results and discussion
To identify proteins that when phosphorylated by SFKs become
binding partners for the CrkL SH2 domain, we employed a quanti-
tative functional proteomics screen. HEK 293 cells were grown in
SILAC media and treated with H2O2 which serves as a general tyro-
sine phosphatase inhibitor [19], thereby dramatically boosting the
levels of tyrosine phosphorylation on substrates of endogenous
tyrosine kinases. While both light and heavy SILAC cells were trea-
ted with H2O2, heavy cells were pre-treated with PP2, a relatively
speciﬁc inhibitor of SFKs [20]. Anti-phosphotyrosine immunoblots
of whole cell extracts showed that H2O2 generally increased phos-
photyrosine levels while PP2 reduced H2O2-stimulated phosphoty-
rosine levels. Furthermore, pulldown assays showed that a subset
of the tyrosine phosphorylated proteins following H2O2 stimula-
tion interacted with GST-CrkL-SH2 but not with GST alone. Addi-
tionally, the binding of several of these proteins to GST-CrkL-SH2
was sensitive to PP2 (Fig. 1A). We thus proceeded with a large-
scale pulldown experiment using the same extracts. Heavy and
light SILAC extracts were mixed one-to-one and were subjected
to pulldowns with GST or with GST-CrkL-SH2. Both the GST-bound
proteins and the GST-CrkL-SH2-bound proteins were eluted sepa-
rately and subjected to SDS–PAGE. The gels were then cut into
multiple regions and digested in-gel with trypsin. Extracted
peptides were analyzed by liquid chromatography (LC)–mass spec-
Fig. 1. SILAC-based quantitative functional proteomics identiﬁes Cas and ESDN as PP2-sensitive tyrosine kinase substrates that interact with the CrkL-SH2 domain. HEK 293
cells were grown in control media (C), heavy (H) media, or light (L) media and treated as indicated. Whole cell extracts (WCE) were subjected to SDS–PAGE and
immunoblotting directly (A, left panel) or after pulldown assays using either GST or GST-CrkL-SH2 (A, right panel). Blots were probed with anti-phosphotyrosine antibodies.
⁄Indicates the position of GST-CrkL-SH2 background reactivity. (B) SILAC ratios for ESDN and Cas peptides are statistically different (P < 0.001) from all other proteins. The
mean SILAC ratio of all peptides is the vertical light gray line, whereas the dark vertical line is the mean SILAC ratio of all peptides less those peptides from ESDN and Cas.
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etry platform. SILAC ratios were determined for all peptides from
proteins uniquely bound to the CrkL-SH2 domain. Fig. 1B shows
the two proteins that had SILAC ratios that were statistically differ-
ent from those of all other identiﬁed proteins. These two proteins,
Cas and ESDN, presented a proﬁle consistent with SFK-dependent
CrkL-SH2 binding.
While the intracellular scaffolding protein Cas has been exten-
sively studied, and was ﬁrst identiﬁed as a substrate of SFKs that
bound to Crk more than two decades ago [11], ESDN (Fig. 2A) is
predicted to be a single-pass, orphan receptor and little is known
about its signaling. The Crk/CrkL SH2 domain docks at phosphory-
lated tyrosine residues in the minimal consensus motif YxxP. Scan-
site [21] bioinformatically predicts 16 possible Crk-SH2 YxxP
binding motifs in Cas and six in the intracellular domain of ESDN.
One additional intracellular YxxP motif is also found in ESDN
(Fig. 2B). We obtained a clone of ESDN with a carboxyl-terminal
Flag tag and designed three ESDN-Flag mutant constructs withtyrosine to phenylalanine mutations at predicted Crk/CrkL-SH2
binding YxxP motifs. The constructs harbored mutations at either
the top predicted, the top three predicted, or all seven YxxP tyro-
sines (Fig. 2B). As shown in Fig. 2C, cells transfected with these
constructs and treated with H2O2 generated ESDN molecules capa-
ble of binding to the CrkL-SH2 domain in all cases except when all
seven of the YxxP tyrosines were mutated to phenylalanine.
To determine if ESDN underwent reversible tyrosine phosphor-
ylation at YxxP tyrosines we immunoprecipitated ESDN-Flag from
the same extracts used in the GST-CrkL-SH2 pulldowns (Fig. 2C).
All constructs, including the Y7F, showed reversible tyrosine phos-
phorylation as measured by anti-phosphotyrosine immunblotting
with the Y7F showing dramatically reduced anti-phosphotyrosine
immunoreactivity (Fig. 2C). This is consistent with reversible phos-
phorylation at several ESDN YxxP tyrosines participating in the
binding to the CrkL-SH2 domain. To identify sites of reversible
tyrosine phosphorylation, we conducted another SILAC experiment
where light cells were transfected with wild type ESDN-Flag and
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ESDN-Flag and left untreated. Anti-Flag immunoprecipitations
were conducted on the two extracts separately. After denaturing
the immune complexes, the two samples were combined and sub-
jected to SDS–PAGE. In-gel tryptic digestion and LC–MS/MS analy-
sis of the extracted peptides identiﬁed four ESDN tryptic peptides
harboring phosphotyrosine (Supplementary Figs. 1–5). These phos-
phopeptides were only identiﬁed in the stimulated, light samples
and based on signal to noise we concluded that H2O2 induced a
50-fold increase in the four identiﬁed phosphopeptides. Three
of the identiﬁed phosphotyrosyl-peptides were in YxxP motifs,
and consistent with an increase in phosphotyrosine at a non-YxxP
motif in the ESDN-Flag Y7F mutant (Fig. 2C), one of the identiﬁed
phosphopeptides was not in a YxxP motif (Y715). The sites that
we identiﬁed have already been curated in PhosphoSitePlus [22],
having been identiﬁed in many large-scale phosphoproteomic
experiments (Supplementary Fig. 1).
Well-studied examples exist where SFKs and Crk/CrkL not only
coordinate their activities around a scaffold, but the molecular
complex they form is perpetuated by a positive feedback loop. It
is well understood that in unstimulated cells a SFK typically exists
in a folded, low activity conformation with its SH2 domain intra-Fig. 2. (A) ESDN domain structure and corresponding human amino acids including the se
of the Crk-SH2 binding motif aligned with the ESDN intracellular YxxP motif sequence
binding. Note putative phosphotyrosine residues are at position zero. (C) Multiple regu
domain. HEK 293 cells transfected with the indicated constructs were treated as indica
with the indicated antibodies, or after being subjected to either GST-CrkL-SH2 pulldowns
of the membrane prior to immunoblotting indicates the levels of the transferred GST-Cmolecularly bound to its C-terminal Src kinase (CSK)-phosphory-
lated C-terminal tail [23]. Following a variety of stimuli the
folded structure of an SFK can be opened, primarily by its SH2 do-
main binding to a newly phosphorylated tyrosine on a neighboring
molecule for which it has a higher afﬁnity than for its own C-termi-
nal tail [24]. This is observed for both Cas and Dab1 as they serve as
SFK substrates as well as binding partners for both the SH2 do-
mains of SFKs and Crk/CrkL [11,13,14,18]. However, Cas and
Dab1 are phosphorylated at multiple residues by SFKs with some
residues capable of docking and unfolding SFKs and some capable
of docking Cas/CrkL [11,13,14]. We therefore examined whether
the SH2 domain of a representative SFK, Fyn, showed regulated
binding to ESDN and whether the same ESDN YxxP tyrosines that
were required for CrkL-SH2 binding might participate in Fyn-SH2
binding. Pulldown assays with both GST-CrkL-SH2 and GST-Fyn-
SH2 showed H2O2-induced binding to wild type ESDN but not to
ESDN Y7F (Fig. 3A). Importantly, similar results were obtained
when ESDN was co-expressed with Fyn in the absence of H2O2
Fig. 3B). These results show that active Fyn is sufﬁcient to directly
or indirectly induce ESDN tyrosine phosphorylation and CrkL-SH2
binding. However, while pharmacological inhibition of SFKs with
the highly selective Src Inhibitor-1 (Src-1) [19] led to increasedven intracellular tyrosines found in YxxP motifs. TM = transmembrane. (B) Weblogo
s in descending order (high, medium and low) of their Scansite predicted Crk-SH2
lated phosphotyrosine residues participate in the binding of ESDN to the CrkL-SH2
ted. Whole cell extracts were subjected to SDS–PAGE and immunoblotting directly
(upper panels) or anti-Flag immunoprecipitations (lower panels). The Ponceau stain
rkL-SH2 in each lane. ⁄Indicates non-speciﬁc background bands.
Fig. 3. (A) Wild type but not ESDN Y7F binds to the SH2 domain of Fyn following
H2O2 stimulation. HEK 293 cells were transfected with ESDN-Flag wild type or
ESDN-Flag Y7F and either left untreated or stimulated with H2O2. Whole cell
extracts were subjected to SDS–PAGE and immunoblotting with the indicated
antibodies directly or following pulldown assays with GST-CrkL-SH2 or GST-Fyn-
SH2 fusions. The Ponceau stain of the membranes prior to immunoblotting
indicates the levels of the transferred GST fusion proteins. (B) Fyn induces the
binding of wild type ESDN, but not Y7F ESDN, to the SH2 domains of both CrkL and
Fyn. Cells were treated as in A except that where indicated, Fyn was co-expressed
with ESDN. (C) Pharmacological disruption of SFKs reduces but does not eliminate
H2O2-induced ESDN binding to the CrkL-SH2 domain. Cells stably-expressing ESDN-
Flag were pre-treated with the indicated inhibitors prior to stimulation with H2O2.
Extracts were subjected to immunoblotting before or after GST-CrkL-SH2 pull-
downs as indicated.
Fig. 4. (A) Model depicting possible mechanism by which ESDN acts as a scaffold
for the adaptor CrkL. ESDN’s ectodomains may respond to factors (X, Y, Z) that
induce clustering of ESDN in the proximity of low activity SFKs. ESDN serves as a
substrate for SFKs as well as unidentiﬁed tyrosine kinases at multiple tyrosine
residues, some of which can bind to the SH2 domain of SFK’s and thereby relieve
autoinhibition. Phosphotyrosine sites on ESDN serve as docking sites for CrkL and
other phosphotyrosine-binding proteins. By virtue of primarily its N-terminal SH3
domain, CrkL may recruit additional effector proteins. (B and C) Antibody-induced
clustering induces ESDN tyrosine phosphorylation and its interaction with the CrkL-
SH2 domain. HEK 293 cells expressing wildtype or Y7F ESDN-Flag were treated as
indicated with 2 lg/ml of an anti-ESDN antibody recognizing the extracellular
Factor V/VIII domain. Cells were lysed and extracts were subjected to anti-Flag
immunoprecipitations. Immune complexes and whole cells extracts were blotted
with either anti-phosphotyrosine or anti-Flag antibodies as indicated. ⁄Indicates
non-speciﬁc band. (C) Cells were treated as in (B) except extracts were subjected to
GST-CrkL-SH2 pulldowns prior to immunoblotting.
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CrkL-SH2 domain was retained (Fig. 3C), suggesting that additional
kinases are important in promoting the ESDN–CrkL interaction. Gi-
ven that we identiﬁed hydrogen peroxide induced phosphorylation
of several ESDN tyrosine residues including 715 and 732 (non-
YxxP and YxxP sites respectively, Supplementary Fig. 1), whose
phosphorylation was recently shown to be dependent on SFKs
[25], and given signiﬁcant ESDN binding can be achieved to theCrkL-SH2 domain even when the three best-predicted CrkL-bind-
ing sites are mutated (Fig. 2C), suggest that SFKs can cooperate
with non-SFKs to phosphorylate ESDN and promote a high avidity
binding to the CrkL-SH2 domain. Furthermore, while SFKs physio-
logically phosphorylate YxxP motifs including Dab1 [13], YxxP is
not the preferredmotif for their kinase and SH2 domains. However,
several other kinase families and SH2 domains could easily con-
tribute to ESDN phosphorylation and ESDN binding [2–4] are these
are currently being pursued.
ESDN appears to be unique to, and highly conserved among,
vertebrates, with all seven of the intracellular YxxP motifs con-
served from human to ﬁsh and frog (Supplementary Fig. 6). ESDN
is best understood and was originally identiﬁed as a marker of vas-
cular endothelial cells [26,27]. However, it has also been described
as a marker of platelets and some cancers [28–31]. Additionally,
the extracellular domain structure of ESDN is reminiscent of neu-
2318 T.M. Aten et al. / FEBS Letters 587 (2013) 2313–2318ropilins which are receptors/co-receptors involved in neuronal
migration [26]. It will be important in future studies to describe
the individual cell types that express ESDN in a variety of systems
and to elucidate both its biological functions, and its mechanisms
of signal transduction. We propose an introductory signaling mod-
el for ESDN involving SFKs and other tyrosine kinases (Fig. 4A). In
this model several possible extracellular ligands could function in
autocrine or paracrine fashion to cluster ESDN molecules. The clus-
tering concentrates ESDN molecules sufﬁciently that the relatively
inactive SFK, which is linked to the membrane via a lipid moiety,
begins to phosphorylate a few ESDN molecules. This could lead
to Fyn’s SH2 domain binding to phosphorylated ESDN and thereby
relieving its autoinhibition [24]. Simple thermodynamic processes
[32] and a positive feedback loop could then lead to a highly phos-
phorylated pool of ESDN and the direct binding of several types of
proteins with phosphotyrosine-binding domains, including CrkL,
whose N-terminal SH3 domain binds many proteins that could
govern changes in cell adhesion or migration proteins [33]. Consis-
tent with this model, we ﬁnd that a presumed clustering of ESDN
by treating ESDN-expressing cells with a bivalent (IgG) antibody
against the Factor V/VIII extracellular domain induces ESDN tyro-
sine phosphorylation and its binding to the CrkL-SH2 domain
(Fig. 4B-C).
In this study we used a functional proteomics screen to identify
SFK substrates that serve as scaffolds for the CrkL adaptor protein.
We identiﬁed the orphan receptor ESDN. Our data describe a nas-
cent signaling pathway and deﬁne avenues of related future re-
search. These avenues include the identiﬁcation of the
extracellular ligands that activate or perhaps cluster ESDN, the
identiﬁcation of additional ESDN kinases, the identiﬁcation of
intracellular phospho-dependent ESDN binding proteins that effec-
tuate ESDN signaling, the identiﬁcation of downstream ESDN sig-
naling events, and ultimately functional studies of ESDN using
vertebrate systems.
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